文献速递传染病防控与疫情报告职业卫生

澳大利亚马亨德拉病毒疫苗接种的时空下降趋势与风险持续并存

Longitudinal and spatial declines in equine Hendra virus vaccination despite continued risk.
PubMed 文献 · Vaccine · 2026-07-22

本研究分析2012至2023年澳大利亚马亨德拉病毒(HeV)疫苗接种的时空趋势及人口学与生态学预测因素。接种高度季节性,且接种兽医密度是最强预测因素。

要点

  • 马HeV疫苗接种自2014-2015年起在时空上下降,高风险区亦如此。
  • 疫苗接种呈高度季节性,接种兽医密度是最强预测因素。
  • 尽管疫苗高效,维持罕见高后果病原体的接种项目面临挑战。

核心结论

  • 马HeV疫苗接种自2014-2015年起在时空上下降,包括已知高风险区域。
  • 接种兽医密度是马HeV疫苗接种的最强预测因素。

研究设计与样本

  • 本研究探索2012至2023年澳大利亚马HeV疫苗接种的精细空间尺度趋势,并识别人口学与生态学预测因素。

主要发现

  • 马HeV疫苗接种自2014-2015年起在时空上均下降,包括已知高风险区域。
  • 疫苗接种高度季节性。
  • 接种HeV疫苗的兽医密度是马HeV疫苗接种的最强预测因素。

临床怎么用

  • 马HeV疫苗高效预防蝙蝠至马的溢出传播并保护人类,但需关注接种下降趋势及接种兽医密度对维持接种项目的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hendra virus is an emerging zoonosis endemic to Australia with high fatality of infection in horses and humans. The role of infected domestic horses as amplifying bridge hosts for onward transmission to humans led to the creation of an equine vaccine as a One Health solution against spillover. Despite the risk this disease represents, previously reported equine vaccination rates were low. This study explored vaccination trends between 2012 and 2023 at fine spatial scales and identified demographic and ecological predictors of vaccination against emerging zoonoses. Over 1 million doses of Equivac® HeV were delivered within Australia over this time. The vaccination against Hendra virus has declined since 2014-2015 across both space and time, including within areas of known high risk. Vaccine uptake was highly seasonal, and the density of HeV-vaccinating veterinarians was the strongest predictor of equine vaccination against Hendra virus. While the equine HeV vaccine is highly effective in preventing spillover from bats to horses and thereby protecting people, our results highlight the challenges in sustaining vaccination programs for rare, high consequence pathogens across bridge host populations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Linnegar B, McCallum H, Peel AJ, et al. Longitudinal and spatial declines in equine Hendra virus vaccination despite continued risk. Vaccine. 2026. PMID: 42492241. doi:10.1016/j.vaccine.2026.128937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。